New Life announced that the first meeting of the third board of directors of the company elected Wang Xiaoming as the chairman of the third board of directors, and elected members and directors of various special committees of the board of directors; appointed Wang Xuezhao as general manager, Xu Yonggang and Guo Chunsheng as deputy general manager, Xu Yonggang also served as board secretary, Xu Jiangping as financial director, Zhou Song as head of internal audit, and Liu Chunlei as securities affairs representative. The terms of office of the above personnel have all been elected until the end of the current board of directors. In addition, the meeting reviewed and passed proposals such as revising the draft major asset restructuring report, approving the extended evaluation report, and extending the validity of the asset restructuring shareholders' meeting resolution until October 9, 2027. Among them, the matter of extending the validity period still needs to be submitted to the shareholders' meeting for consideration. The company plans to hold the 2026 3rd Extraordinary Shareholders' Meeting on October 15, 2026.

New Life announced that the first meeting of the third board of directors of the company elected Wang Xiaoming as the chairman of the third board of directors, and elected members and directors of various special committees of the board of directors; appointed Wang Xuezhao as general manager, Xu Yonggang and Guo Chunsheng as deputy general manager, Xu Yonggang also served as board secretary, Xu Jiangping as financial director, Zhou Song as head of internal audit, and Liu Chunlei as securities affairs representative. The terms of office of the above personnel have all been elected until the end of the current board of directors. In addition, the meeting reviewed and passed proposals such as revising the draft major asset restructuring report, approving the extended evaluation report, and extending the validity of the asset restructuring shareholders' meeting resolution until October 9, 2027. Among them, the matter of extending the validity period still needs to be submitted to the shareholders' meeting for consideration. The company plans to hold the 2026 3rd Extraordinary Shareholders' Meeting on October 15, 2026.